Target Name: ZMYND19
NCBI ID: G116225
Other Name(s): ZMY19_HUMAN | zinc finger, MYND domain containing 19 | zinc finger MYND-type containing 19 | MCH-R1-interacting zinc finger protein | Melanin-concentrating hormone receptor 1 interacting zinc-finger protein | RP11-48C7.4 | melanin-concentrating hormone receptor 1 interacting zinc-finger protein | Zinc finger MYND domain-containing protein 19 | Zinc finger MYND-type containing 19 | Zinc finger, MYND domain containing 19 | Melanin-concentrating hormone receptor 1-interacting zinc finger protein | MIZIP

ZMY19: A Potential Drug Target and Biomarker

ZMYND19 (ZMY19_HUMAN), a gene that encodes for a protein known as ZMY19, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZMY19 is a transmembrane protein that plays a crucial role in the regulation of cellular processes, including cell adhesion, migration, and survival.

The identification of ZMY19 as a potential drug target and biomarker has been the focus of extensive research, both in the laboratory and in animal models. Researchers have identified numerous potential drug candidates that target ZMY19, and initial studies have shown promise in using these compounds to treat a range of diseases.

One of the most promising aspects of ZMY19 is its role in cancer. Cancer is a leading cause of death worldwide, and there is a significant need for new, effective treatments. ZMY19 has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancer.

Research has also suggested that ZMY19 may be involved in neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. These conditions are characterized by the progressive loss of brain cells and can lead to a range of symptoms, including memory loss, stiffness, and difficulty with movement.

ZMY19 has also been implicated in autoimmune disorders, such as rheumatoid arthritis and lupus. These conditions involve an overactive immune system that can cause inflammation and damage to body tissues.

In addition to its potential as a drug target and biomarker, ZMY19 is also of interest to researchers as a potential therapeutic agent for a range of other diseases. For example, ZMY19 has been shown to be involved in the regulation of cell signaling pathways that are important for many cellular processes, including cell growth, differentiation, and survival. This suggests that it may be a useful agent for treating conditions that involve these processes, such as neurodegenerative diseases and cancer.

Overall, the potential of ZMY19 as a drug target and biomarker for a range of diseases makes it an important area of research. Further studies are needed to fully understand its role in these conditions and to develop safe and effective treatments.

Protein Name: Zinc Finger MYND-type Containing 19

Functions: May be involved as a regulatory molecule in GPR24/MCH-R1 signaling

More Common Targets

ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260